HPA015015
antibody from Atlas Antibodies
Targeting: SCYL1
GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA015015 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA015015, RRID:AB_1856643
- Product name
- Anti-SCYL1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SCYL1, Gene description: SCY1-like 1 (S. cerevisiae), Alternative Gene Names: GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP, Validated applications: ICC, Uniprot ID: Q96KG9, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references mTORC1 controls Golgi architecture and vesicle secretion by phosphorylation of SCYL1.
SCYL1 arginine methylation by PRMT1 is essential for neurite outgrowth via Golgi morphogenesis
SCYL1 does not regulate REST expression and turnover
Kaeser-Pebernard S, Vionnet C, Mari M, Sankar DS, Hu Z, Roubaty C, MartÃnez-MartÃnez E, Zhao H, Spuch-Calvar M, Petri-Fink A, Rainer G, Steinberg F, Reggiori F, Dengjel J
Nature communications 2022 Aug 10;13(1):4685
Nature communications 2022 Aug 10;13(1):4685
SCYL1 arginine methylation by PRMT1 is essential for neurite outgrowth via Golgi morphogenesis
Amano G, Matsuzaki S, Mori Y, Miyoshi K, Han S, Shikada S, Takamura H, Yoshimura T, Katayama T, Kaibuchi K
Molecular Biology of the Cell 2020;31(18):1963-1973
Molecular Biology of the Cell 2020;31(18):1963-1973
SCYL1 does not regulate REST expression and turnover
Anto R, Gingras S, Kuliyev E, Pelletier S
PLOS ONE 2017;12(6):e0178680
PLOS ONE 2017;12(6):e0178680
No comments: Submit comment
No validations: Submit validation data